AUM Biosciences merges with Mountain Crest Acquisition to become public company
The transaction reflects a pre-money equity value of $400 million for AUM Biosciences
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
AUM Biosciences
AUM Biosciences announces closing of $27 million in a “Series A” round of funding
This round was led by Singapore-based Everlife and SPRIM Global investments (SGI)